{
    "clinical_study": {
        "@rank": "158170", 
        "arm_group": [
            {
                "arm_group_label": "singelton pregnancy", 
                "description": "will be followed 11-14 weeks and 19-28 weeks of gestation and after birth"
            }, 
            {
                "arm_group_label": "twin pregnancy", 
                "description": "will be followed 11-14 weeks and 19-28 weeks of gestation and after birth"
            }
        ], 
        "biospec_descr": {
            "textblock": "Maternal serum"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether we can establish different markers suc as\n      mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood\n      and more un the first trimester, in order to screen for twin pregnancies that are more\n      likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses."
        }, 
        "brief_title": "Establishing First Trimester Markers for the Identification of High Risk Twin", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Small for Gestational Age (Disorder)", 
            "Pre-Eclampsia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Eclampsia", 
                "Pre-Eclampsia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  pregnant women from 11 -14 weeks of gestation\n\n        Exclusion Criteria:\n\n          -  nuchal thickness above 3 mm,\n\n          -  Chronic hypertension,\n\n          -  thrombophilia,\n\n          -  Diabetes"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "pregnant women that will come to our first trimester clinic inorder to preform first\n        trimester screeninig"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031393", 
            "org_study_id": "217/13"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Be'er Ya`aqov", 
                    "country": "Israel", 
                    "state": "Zrifin", 
                    "zip": "70300"
                }, 
                "name": "Assaf Harofe obstetric department"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "2", 
        "official_title": "Establishing First Trimester Sonographic, Biochemical and Clinical Markers for the Identification of High Risk Twin in the First Trimester", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "the women will be approached after birth to asses whether they developed preeclampsia or pregnancy induced hypertension", 
            "measure": "The development  of preeclampsia", 
            "safety_issue": "No", 
            "time_frame": "after delivery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031393"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "intra uterine growth restriction", 
            "safety_issue": "No", 
            "time_frame": "after delivery"
        }, 
        "source": "Assaf-Harofeh Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assaf-Harofeh Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2009", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "9 Months", 
        "verification_date": "December 2013"
    }
}